These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8593126)

  • 1. The genetic determinants of plasma cholesterol and response to diet.
    Humphries SE; Peacock RE; Talmud PJ
    Baillieres Clin Endocrinol Metab; 1995 Oct; 9(4):797-823. PubMed ID: 8593126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus.
    Sankaranarayanan K; Chakraborty R; Boerwinkle EA
    Mutat Res; 1999 Jan; 436(1):21-57. PubMed ID: 9878681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoproteins, quantitative lipoprotein traits and multifactorial hyperlipidaemia.
    Utermann G
    Ciba Found Symp; 1987; 130():52-69. PubMed ID: 2965000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of the hyperlipidemias and coronary artery disease.
    Berg K
    Prog Clin Biol Res; 1982; 103 Pt B():111-25. PubMed ID: 7163216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lipids in cardiovascular disease: lessons from rare mutations and special populations.
    Hegele RA
    Clin Invest Med; 1996 Jun; 19(3):161-70. PubMed ID: 8724819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E and complement C3 polymorphism and their role in the response to gemfibrozil and low fat low cholesterol therapy.
    Nemeth A; Szakmary K; Kramer J; Dinya E; Pados G; Fust G; Huettinger M
    Eur J Clin Chem Clin Biochem; 1995 Nov; 33(11):799-804. PubMed ID: 8620056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics of lipid diseases.
    Ordovas JM
    Hum Genomics; 2004 Jan; 1(2):111-25. PubMed ID: 15601539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of measured genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipoprotein and triglyceride levels.
    Boerwinkle E; Sing CF
    Ann Hum Genet; 1987 Jul; 51(3):211-26. PubMed ID: 3688836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA polymorphisms at the lipoprotein lipase gene and their association with quantitative variation in plasma high-density lipoproteins and triacylglycerides.
    Mitchell RJ; Earl L; Bray P; Fripp YJ; Williams J
    Hum Biol; 1994 Jun; 66(3):383-97. PubMed ID: 8026810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of variability of CHD risk.
    Sing CF; Moll PP
    Int J Epidemiol; 1989; 18(3 Suppl 1):S183-95. PubMed ID: 2807701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks for hyperlipidemia.
    Nestruck AC; Davignon J
    Cardiol Clin; 1986 Feb; 4(1):47-56. PubMed ID: 2871933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in apolipoprotein and lipid levels in an HIV-infected Brazilian population under different treatment profiles: the relevance of apolipoprotein E genotypes and immunological status.
    Malavazi I; Abrão EP; Mikawa AY; Landgraf VO; da Costa PI
    Clin Chem Lab Med; 2004 May; 42(5):525-32. PubMed ID: 15202789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of DNA polymorphisms of the apolipoprotein genes to study the role of genetic variation in the determination of serum lipid levels.
    Humphries SE; Talmud PJ; Kessling AM
    Ciba Found Symp; 1987; 130():128-49. PubMed ID: 2894927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
    Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
    Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
    Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
    Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of serum lipids by soy protein and soluble fiber is not associated with the ABCG5/G8, apolipoprotein E, and apolipoprotein A1 polymorphisms in a group of hyperlipidemic Mexican subjects.
    Torres N; Guevara-Cruz M; Granados J; Vargas-Alarcón G; González-Palacios B; Ramos-Barragan VE; Quiroz-Olguín G; Flores-Islas IM; Tovar AR
    Nutr Res; 2009 Oct; 29(10):728-35. PubMed ID: 19917453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France.
    Dallongeville J; Meirhaeghe A; Cottel D; Fruchart JC; Amouyel P; Helbecque N
    Atherosclerosis; 2000 May; 150(1):149-57. PubMed ID: 10781646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
    de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
    Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.